Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mallinckrodt PLC

Latest From Mallinckrodt PLC

Piramal Pharma Stake Sale On Track, Gains Seen For Contract Business Amid Pandemic

Piramal Enterprises, which is in the process of fund raising for its pharma business, says it's well geared to cater to evolving requirements in the sector amid COVID-19 given its global manufacturing footprint with a strong compliance record. Pharma, the Indian firm’s management maintains, is one of the ‘safest and most resilient’ industries in the current uncertainty.

Commercial Coronavirus COVID-19

Keeping Track Of US FDA Decisions: Approvals For Ongentys And New Keytruda, Darzalex Dosing, But Not For Trevyent

The latest US FDA approval decision news and highlights from the Pink Sheet’s FDA Performance Tracker

US FDA Performance Tracker Drug Review

New Opioid Battlefront: New York Charges Mallinckrodt With Insurance Fraud

The allegations (that Mallinckrodt misrepresented safety and efficacy) are similar to other suits but the insurance avenue provides another route to obtain financial remuneration.

Legal Issues Advertising, Marketing & Sales

Stockwatch: Repeating Past Mistakes At AbbVie

AbbVie’s latest, largest acquisition may be cast in a new light as the pandemic throws stock markets into turmoil and commercial prospects up in the air.

M & A Stockwatch
See All

Company Information